Health Condition 1: L209- Atopic dermatitis, unspecified
Conditions
Interventions
dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm. Patients will be instructed to mai
dosage and repetition depending upon the individual requirement of the cases. Patients will be instructed to maintain local hygiene. Duration of therapy: 6 months.
Sponsors
Mahesh Bhattacharyya Homoeopathic Medical College Hospital Govt of West Bengal
Eligibility
Inclusion criteria
Inclusion criteria: 1. Newly diagnosed cases of AD (ICD-10-CM code L20.9) as per UK diagnostic criteria 2. PO-SCORAD more than 10 3. Age: 18-65 years 4. Both sexes 5. Literate patients; ability to read Bengali 6. Patients giving written consent to participate 7. Patients already undergoing treatment for AD were planned to be recruited on completely stopping the medicines and after wash-out phase of 1 month
Exclusion criteria
Exclusion criteria: 1. Patients who were too sick for consultation 2. Diagnosed cases of unstable psychiatric or uncontrolled or life-threatening systemic illness affecting QoL or any organ failure 3. Substance abuse and/or dependence 4. Pregnant and lactating women 5. Patients undergoing homeopathic treatment for any chronic disease within last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient-oriented Scoring of Atopic Dermatitis (PO-SCORAD)Timepoint: At baseline, and every month up to 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Atopic Dermatitis Burden Scale for Adults (ADBSA)Timepoint: At baseline, and every month up to 6 months;Dermatological Life Quality Index (DLQI) questionnaireTimepoint: At baseline, and every month up to 6 months | — |
Countries
India
Contacts
Public ContactShubhamoy Ghosh
Mahesh Bhattacharyya Homoeopathic Medical College and Hospital, Govt. of West Bengal
Outcome results
None listed